GSK Share Price

Open 1550.00 Change Price %
High 1558.42 1 Day -6.50 -0.42
Low 1542.50 1 Week -39.00 -2.46
Close 1546.50 1 Month 18.75 1.23
Volume 6319708 1 Year 178.50 13.05
52 Week High 1745.56
52 Week Low 1314.26
GSK Important Levels
Resistance 2 1561.26
Resistance 1 1555.18
Pivot 1549.14
Support 1 1537.82
Support 2 1531.74
LON UK Most Active Stocks
GGP 0.39 39.29%
GGP 0.39 39.29%
GGP 0.39 39.29%
FITB 0.30 -16.67%
FITB 0.30 -16.67%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LLOY 65.07 0.51%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
LDP 0.03 50.00%
LDP 0.03 50.00%
OTC 0.03 50.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

GlaxoSmithKline PLC (LON: GSK)

GSK Technical Analysis 3
As on 20th Jan 2017 GSK Share Price closed @ 1546.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1542.23 & Buy for SHORT-TERM with Stoploss of 1534.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
GSK Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
GSK Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.gsk.com
GSK Address
GSK
980 Great West Road
Brentford, TW8 9GS
United Kingdom
Phone: 44 20 8047 5000
Interactive Technical Analysis Chart GlaxoSmithKline PLC ( GSK LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GlaxoSmithKline PLC
GSK Business Profile
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company’s nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.